OPEN END TURBO OPTIONSSCHEIN LONG - BECTON DICKINSON AND CO. Share Price

Certificat

DE000GZ0UT77

Real-time BOERSE MUENCHEN 13:25:23 18/06/2024 BST
2.56 EUR 0.00% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - BECTON DICKINSON AND CO.
Current month+12.28%
1 month-10.18%
Date Price Change
18/06/24 2.56 0.00%
17/06/24 2.56 -0.78%
14/06/24 2.58 +7.05%
13/06/24 2.41 -10.74%
12/06/24 2.7 -7.22%

Real-time BOERSE MUENCHEN

Last update June 18, 2024 at 01:25 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Goldman Sachs
WKN GZ0UT7
ISINDE000GZ0UT77
Date issued 28/09/2022
Strike 206 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.51
Lowest since issue 1.65
Spread 0.1
Spread %3.85%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232.8 USD
Average target price
279.2 USD
Spread / Average Target
+19.95%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW